ArticleJournal of experimental & clinical cancer research : CR2019

Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC.

Vincenza Ciaramella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.